A Novel Approach Targeting Coagulase-Negative Staphylococcal Infections: Rifabutin's Antibacterial Potential
Clinical Laboratory · 2026 · 72 (05/2026)
DOI: 10.7754/clin.lab.2025.250458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Laboratory, 2026. Verfasst von Hind AbdulMajed und 17 weiteren Autor:innen. Hauptthemen laut MEDLINE: Rifabutin, Anti-Bacterial Agents, Staphylococcal Infections, Staphylococcus.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
AbdulMajed, H., Attallah, D. M., Mokhtar, J. A., Alhussainy, S., Alqarni, M. A., Alhussainy, N. H., Niyazi, H. A., Niyazi, H. A., Alsufyani, H. A., Alkuwaity, K. K., Alhazmi, W., Sait, A. M., Mufrrih, M., Alharbi, M. T., Altalhi, R., Alharbi, O. S., Alfadil, A., & Ibrahem, K. (2026). A Novel Approach Targeting Coagulase-Negative Staphylococcal Infections: Rifabutin's Antibacterial Potential. Clinical Laboratory, 72(05/2026). https://doi.org/10.7754/clin.lab.2025.250458
Vancouver
AbdulMajed H, Attallah DM, Mokhtar JA, Alhussainy S, Alqarni MA, Alhussainy NH, et al. A Novel Approach Targeting Coagulase-Negative Staphylococcal Infections: Rifabutin's Antibacterial Potential. Clinical Laboratory. 2026;72(05/2026). doi:10.7754/clin.lab.2025.250458
BibTeX
@article{AbdulMajed2026,
author = {AbdulMajed, Hind and Attallah, Dalya M and Mokhtar, Jawahir A and Alhussainy, Shahad and Alqarni, Mona A and Alhussainy, Nabeel H and Niyazi, Hatoon A and Niyazi, Hanouf A and Alsufyani, Hadeel A and Alkuwaity, Khalil K and Alhazmi, Wafaa and Sait, Ahmad M and Mufrrih, Mohammed and Alharbi, Mohammed T and Altalhi, Rawan and Alharbi, Ohood S and Alfadil, Abdelbagi and Ibrahem, Karem},
title = {A Novel Approach Targeting Coagulase-Negative Staphylococcal Infections: Rifabutin's Antibacterial Potential},
journal = {Clinical Laboratory},
year = {2026},
volume = {72},
number = {05/2026},
doi = {10.7754/clin.lab.2025.250458}
}
EUVIMED